Tag: <span>Cholesterol Drug’s</span>

Home / Cholesterol Drug’s
Post

Synthetic drug ebselen could be repurposed to treat SARS-CoV-2 by targeting main protease at distant

Molecular characterization of ebselen binding activity to SARS-CoV-2 main protease AMERICAN ASSOCIATION FOR THE ADVANCEMENT OF SCIENCE The synthetic drug ebselen can bind to both the catalytic region and a previously unknown distant site on the SARS-CoV-2 virus’ main protease, according to a molecular simulation analysis of the drug’s interactions with this enzyme. The results...

Post

Out-of-pocket costs often keep pricey new cholesterol drugs out of reach, study finds

Access to powerful new cholesterol-lowering drugs is so tightly controlled and patients’ out-of-pocket costs are so high that fewer than a third of people whose doctors prescribe the drugs get them, a new study found. While highly effective, the new drugs cost as much as $14,000 annually, leading some insurers and pharmacy benefit managers to require doctors...